¹øÈ£ |
¼º¸í |
¼Ò¼Ó |
Á¦¸ñ |
GO1 |
±Ç¼ö°æ |
¿ï»êÀÇ´ë |
Do clear cell carcinomas have poorer survival than serous carcinomas of ovary? A case-control study |
GO2 |
ÀüÀºÁø |
¿ï»êÀÇ´ë |
Treatment outcome of carcinosarcoma of ovary: Comparison with serous epithelial ovarian carcinoma |
GO3 |
ÀÓ¸íö |
±¹¸³¾Ï¼¾ÅÍ Àڱþϼ¾ÅÍ |
Clinical Maniestations in Patients with Endometrioid Epithelial Ovarian Cancer With or Without Co-existing Endometriosis: A Multicenter Retrospective Study |
GO4 |
ÀÓ¸íö |
±¹¸³¾Ï¼¾ÅÍ Àڱþϼ¾ÅÍ |
Region-based Diagnostic Performance of Multi-detector CT for Detecting Peritoneal Seeding in Ovarian Cancer Patients |
GO5 |
À̽ÅÈ |
¿ï»êÀÇ´ë |
Effective radiation therapy for recurrent epithelial ovarian cancer after chemotherapy as the palliative and salvage treatment |
GO6 |
ÀÌ»êÈñ |
¿¬¼¼ÀÇ´ë |
The impact of lymph node ratio on tumor recurrence and survival after staging laparotomy for advanced epithelial ovarian cancer |
GO7 |
Àü°æö |
¿ï»êÀÇ´ë |
Optimal debulking surgery followed by paclitaxel /platinum chemotherapy; Effective management in ovarian malignant mixed mullerian tumors |
GO8 |
ÀÌÁ¤¿ø |
°¡Å縯ÀÇ´ë |
Clinical outcomes of atypical borderline ovarian tumor |
GO9 |
Á¤¾ð¼® |
°Ç¾çÀÇ´ë |
The impact of laparoscopically-assisted staging surgery for ovarian or tubal cancers : Intermediate-term oncologic outcomes |
GO10 |
À±¼®±Ù |
°üµ¿ÀÇ´ë |
Second-look laparoscopy in advanced epithelial ovarian cancer |
GO11 |
°¿ì´ë |
Àü³²ÀÇ´ë |
Value of Serum CA125 Levels in Patients with High-risk, Early Stage Epithelial Ovarian Cancer |
GO12 |
À±Àç¿ø |
¿ï»êÀÇ´ë |
Outcomes of fallopian tube carcinoma treated with cytoreductive surgery followed by adjuvant platinum-based chemotherapy |
GO13 |
¹ÚÁ¤¿ |
¿ï»êÀÇ´ë |
Management of occult invasive cervical cancer found after simple hysterectomy |
GO14 |
±è¿ì¿µ |
¾ÆÁÖÀÇ´ë |
Treatment patterns and outcomes in bulky stage IB2 cervical cancer patients: A single institution¡¯s experience over 14 years |
GO15 |
±èÀçÁØ |
¿ï»êÀÇ´ë |
Comparison of chemotherapy and concurrent chemoradiotherapy as adjuvant treatment in cervical cancer patient with intermediate and high risk factors: A matched case-control study |
GO16 |
ÃÖÈ«ÁØ |
°üµ¿ÀÇ´ë |
Neoadjuvant Chemotherapy with Paclitaxel and Platinum in Uterine Cervical Cancer: Histologic Clinicopathologic Outcome of Squamous Cell Carcinoma Versus Adenocarcinoma |
GO17 |
±è¹Ì°æ |
¼¿ïÀÇ´ë |
Feasibility of conservative management for stage IB1 cervical cancer with invasion depth of less than 5 mm (microinvasive carcinoma) |
GO18 |
±èÈñ½Â |
¼¿ïÀÇ´ë |
Concealing Effect by Neoadjuvant Chemotherapy in FIGO stage IB1-IIA Cervical Cancer |
GO19 |
Jintendra Pariyar |
¿ï»êÀÇ´ë |
Diagnostic accuracy of magnetic resonance imaging in predicting myometrial invasion and cervical involvement in endometrial cancer |
GO20 |
°ûÇö¼º |
°¡Å縯ÀÇ´ë |
Effect of systematic pelvic lymphadenectomy in early stage endometrial cancer: a randomized study in Korea |
GO21 |
±èÈñ½Â |
¼¿ïÀÇ´ë |
Impact of Lymphadenectomy on Survival in Endometrial Carcinoma: A Systematic Review and Meta-analysis |
GO22 |
±èÈñ½Â |
¼¿ïÀÇ´ë |
Value of Serum CA-125 levels for Preoperative Counseling in Endometrioid Endometrial Cancer |
GO23 |
ÀÓÇü¼ö |
¼¿ïÀÇ´ë |
Clinical Analysis of 15 Cases of Low Grade Endometrial Stromal Sarcoma |
GO24 |
±è¿ìö |
°üµ¿ÀÇ´ë |
Conservative Treatment with Progestin And Pregnancy Outcomes in Complex Endometrial Hyperplasia with Atypia |
GO25 |
¹Ú»ó¹Î |
¿ï»êÀÇ´ë |
Àç¹ß¼º Àڱà À°Á¾ÀÇ ÀÓ»ó ¾ç»ó°ú ¿¹ÈÄÀÎÀÚ¿¡ °üÇÑ ¿¬±¸ |
GO26 |
±èº¸¿í |
¿¬¼¼ÀÇ´ë |
The period of hCG follow up may be shortened in the women who achieve spontaneous normalization of hCG after evacuation of hydatidiform mole |
GO27 |
±è¼±¿µ |
¿¬¼¼ÀÇ´ë |
Menopause induced by chemotherapy for GTD |
GO28 |
¼Õâ¾÷ |
¼º±Õ°üÀÇ´ë |
³¼Ò ¼¶À¯Á¾¿¡ ´ëÇÑ °ºÏ»ï¼ºº´¿øÀÇ °æÇè°ú ÀÓ»óÀû °íÂû |
GO29 |
ÀÌÁ¤¿ø |
°¡Å縯ÀÇ´ë |
À¯¹æ¿ÜÆÄÁ¦Æ®º´ÀÇ ÀÓ»óÀû, º´¸®ÇÐÀû °íÂû |
GO30 |
³ëÇöÁø |
¿ï»êÀÇ´ë |
Paget¡¯s disease of the vulva: Evaluation of recurrence relative to symptom duration, volumetric excision of lesion and surgical margin status |
GO31 |
ÇÑÈ£¼· |
°üµ¿ÀÇ´ë |
The Adequacy of Conization in the Management of Adenocarcinoma in situ of the Uterine Cervix |
GO32 |
¼ÒÀºÁ¤ |
¼¿ïÀÇ´ë |
Intentional follow up strategy after loop electrosurgery excision procedure (LEEP) for patients with cervical intraepithelial neoplasia (CIN) 2, 3. |
GO33 |
ÃÖÈ«ÁØ |
°üµ¿ÀÇ´ë |
Clinical and Histological Significance of Atypical Glandular Cells on Cervical Cytology |
GO34 |
°¿ì´ë |
Àü³²ÀÇ´ë |
Distribution of high-risk human papillomavirus genotypes among older women |
GO35 |
À̼ºÁ¾ |
°¡Å縯ÀÇ´ë |
A real time optoelectronic device and colposcopic Reid index in assessment of cervical disease |
GO36 |
¼¹ÎÁ¤ |
°¡Å縯ÀÇ´ë |
ÀڱðæºÎ¾Ï ¼¼Æ÷ÁÖ¿¡¼ÀÇ Mullerian Inhibiting SubstanceÀÇ Áõ½Ä ¾ïÁ¦ È¿°ú |
GO37 |
Á¤´ëÈÆ |
ÀÎÁ¦ÀÇ´ë |
Costimulatory B7-H1 expression in cervical cancer patients |
GO38 |
ÀÓ¸íö |
±¹¸³¾Ï¼¾ÅÍ Àڱþϼ¾ÅÍ |
Expression of carbonic anhydrase XII in cervical cancer is associated with differentiation status and superior radiotherapy outcome |
GO39 |
È«ÁøÈ |
°í·ÁÀÇ´ë |
Expression pattern of the class I homeobox genes in ovarian carcinoma |
GO40 |
äµÎº´ |
¿¬¼¼ÀÇ´ë |
ER-60 (PDIA3) protein is highly expressed in a newly established serous ovarian cancer cell line, YDOV-139 |
GO41 |
Á¶ÇѺ° |
¿¬¼¼ÀÇ´ë |
Expression and function of glucose transporter-1 (GLUT-1) in epithelial ovarian cancer |
GO42 |
±èº¸¿í |
¿¬¼¼ÀÇ´ë |
Overexpression and role of reptin in ovarian cancer |
GO43 |
Á¶¹«¼º |
ºÎ»êÀÇ´ë |
The significance of secreted protein acidic and rich in cysteine(SPARC) in epithelial ovarian cancer |
GO44 |
±è±âÇü |
ºÎ»êÀÇ´ë |
KSP inhibitor ARRY-520 as a substitute for Paclitaxel in MyD88-positive Epithelial ovarian cancer cells |
GO45 |
ÀÓ¹ýÀÎ |
¿ø±¤ÀÇ´ë |
Ç×¾ÏÁ¦ÀÎ CisplatinÀ¸·Î ó¸®µÈ ¹è¾ç¼¶À¯¸ð¼¼Æ÷¿¡ ´ëÇÑ Gallic AcidÀÇ Ç×»êÈ È¿°ú¿¡ °üÇÑ ¿¬±¸ |
GO46 |
ÀÌÁ¤¿ø |
¼º±Õ°üÀÇ´ë |
The Role of MicroRNA-200 family as Therapeutic Targets in Human Endometrial Cancer |
GO47 |
ÃÖöÈÆ |
¼º±Õ°üÀÇ´ë |
Expression of eIF4E and mTOR in endometrial cancer |
GO48 |
°ø°Ç¿µ |
¿ï»êÀÇ´ë |
The Comparison of the Proportion of Peripheral Blood Myeloid-derived Suppressor Cells between gynecologic cancer patients and healthy women |
GO49 |
¹®¼ºÀº |
ÁÁÀº¹®Èº´¿ø |
ÀڱñÙÁ¾°ú Á¤»óÁ¶Á÷¿¡¼ hedgehog ½ÅÈ£Àü´Þü°èÀÇ sonic hedgehog À¯ÀüÀÚ ¹ßÇö ºñ±³ |
GO50 |
¹éÁöÈì |
¿¬¼¼ÀÇ´ë |
Two-port staging laparoscopy for endometrial cancer: The first two cases report |
GO51 |
Á¤¿ë¿í |
¿¬¼¼ÀÇ´ë |
The feasibility of scarless single port transumbilical total laparoscopic hysterectomy: Initial clinical experiences |
GO52 |
ÃÖ¿µ¹Ì |
¿¬¼¼ÀÇ´ë |
Single-port transumbilical laparoscopic approach for adenxal surgery in gynecology |
GO53 |
±è¼ö³ç |
°Ç±¹ÀÇ´ë |
Transvaginal Natural Orifice Transluminal Endoscopic Surgery (NOTES) for Ovarian Cyst |
GO54 |
À̽ÂÈ£ |
°¡ÃµÀÇ´ë |
Àڱ󻸷¾Ï ȯÀÚÀÇ °ñ¹Ðµµ¿¡ °üÇÑ ¿¬±¸ |
GO55 |
ȲÁ¾ÇÏ |
°í·ÁÀÇ´ë |
Bone mineral density in patients with uterine cervical cancer after concurrent chemoradiation |
GO56 |
±âÀº¿µ |
°¡Å縯ÀÇ´ë |
Basal cell carcinoma of the vulva |
GO57 |
Á¶´öÇö |
ºÎ»êÀÇ´ë |
Bowen º´ ȯÀÚ¿¡¼ ¹ß»ýÇÑ HPV infection ÀÌ µ¿¹ÝµÈ ¿ÜÀ½ºÎ»óÇdz»¾Ï ¹× ÀڱðæºÎ»óÇdz»º´º¯ |
GO58 |
äÈñ¼÷ |
ÀüºÏÀÇ´ë |
Paget¡¯s disease of the vulva : report to two cases |
GO59 |
°È£Á¤ |
Á¦ÁÖÀÇ´ë |
syringoma of the vulva |
GO60 |
Á¤À±Áö |
°¡Å縯ÀÇ´ë |
Aggressive angiomyxoma of the vulva: a case report |
GO61 |
À̼ºÇÏ |
°¡Å縯ÀÇ´ë |
Primary malignant melanoma of the vagina |
GO62 |
°øÅ¿í |
¾ÆÁÖÀÇ´ë |
Sarcomatoid squamous cell carcinoma of the uterine cervix successfully treated by laparoscopic radical hysterectomy |
GO63 |
Á¶Çý¿¬ |
ÇѸ²ÀÇ´ë |
A case of clear cell adenocarcinoma in the uterine cervix of 52-year-old virgin |
GO64 |
À̼ºÀÇ |
ºÎ»êÀÇ´ë |
ÀúÇ÷´çÀ» µ¿¹ÝÇÑ Èĺ¹¸· ³» À¯»óÇÇ Ç÷°ü³»ÇÇÁ¾¾ç 1·Ê |
GO65 |
ÃÖÀÏÁ¤ |
µ¿¾ÆÀÇ´ë |
A case of sertoli-leydig cell tumor of ovary with virilization |
GO66 |
Á¤±Ù¿À |
°æºÏÀÇ´ë |
Vaginal evisceration after total laparoscopic radical hysterectomy in cervical cancer |
GO67 |
ÁöÀº¿µ |
°¡Å縯ÀÇ´ë |
Can laparoscopy really complete full surgical staging? A case of early recurrence and malignant transformation of serous borderline ovary tumor |
GO68 |
°û¼¼Çö |
°¡Å縯ÀÇ´ë |
Ovarian cancer at young age: clinicopathologic characteristics and prognosis of epithelial ovarian cancer before age 20 |
GO69 |
¼Û¹ÎÁ¾ |
°¡Å縯ÀÇ´ë |
¾çÃø ³¼Ò¿¡¼ µ¿½Ã¿¡ ¹ß°ßµÈ ¼·Î ´Ù¸¥ Á¶Á÷ÇÐÀû ¼Ò°ß(ÁÂÃø³¼Ò; Serous papillary adenocarcinoma, ¿ìÃø; Mallignant mixed Mullerian tumor)ÀÇ ¾çÃø ³¼Ò¾Ï 1¿¹ |
GO70 |
¹Ú±Ù½Ä |
ÁÁÀº¹®Èº´¿ø |
A unusual case of ovarian fibroma with extensive calcification |
GO71 |
±ÇÇϾá |
¿¬¼¼ÀÇ´ë |
Krukenberg tumor arising from breast cancer : a case of the youngest patient in Korea |
GO72 |
Á¤Áö¾È |
¿¬¼¼ÀÇ´ë |
A case report of gynandroblastoma from ovary : The first case in Korea |
GO73 |
Á¤Áö¿µ |
°í½ÅÀÇ´ë |
Primary Granulocytic Sarcoma of Ovary-A Rare Case Report |
GO74 |
°í¿µº¹ |
Ãæ³²ÀÇ´ë |
¹Ì¼º¼÷±âÇüÁ¾ ¼ö¼úÈÄ °£¿¡ ¹ß»ýÇÑ ¼º¼÷±âÇüÁ¾ 1¿¹ |
GO75 |
±èÁöÇö |
ÇѸ²ÀÇ´ë |
³¼ÒÀÇ ¹Ì¼º¼÷ ±âÇüÁ¾¿¡ °üÇÑ 2¿¹ |
GO76 |
ÃÖÅ¿µ |
ÁÁÀº¹®Èº´¿ø |
º¹ÀâÇÑ ¿°»öü ÀÌ»óÀ» ³ªÅ¸³»´Â ÀڱñÙÁ¾ 2·ÊÀÇ ¼¼Æ÷À¯ÀüÇÐÀû °íÂû |
GO77 |
¹èÁöÇý |
°æºÏÀÇ´ë |
Adenomyomatous polyp of uterus in Peutz-Jeghers syndrome |
GO78 |
¼¹ÎÁ¤ |
°¡Å縯ÀÇ´ë |
ÀÚ±ÃüºÎ¿¡ ¹ß»ýÇÑ ¾Ç¼º ¸²ÇÁÁ¾ 1¿¹ |
GO79 |
Á¤À±¾Æ |
ÇѸ²ÀÇ´ë |
ÀڱðæºÎ ¹Ì¼¼Ä§À±»ù¾ÏÁ¾ ȯÀÚ¿¡¼ °ñ¹Ý ¸²ÇÁÀý ÀüÀÌ 1¿¹ |
GO80 |
ÀÌ°æÈñ |
ÇѸ²ÀÇ´ë |
Àç¹ß¼º Àڱà °æºÎ¾ÏÀÇ ¼Ç츲ÆÄÀý ´Üµ¶ÀüÀÌ 1¿¹ |
GO81 |
ÃÖÀ±Áø |
°¡Å縯ÀÇ´ë |
The Trickery of increased FDG Uptake on PET CT in Foreign-body Reaction; a Case Report |